Unjha Formul.

Unjha_Formul.26 Apr 2024

Pharmaceuticals

₹

+0.50 (+2.60%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Unjha Formul.

Unjha Formul.

Pharmaceuticals

Unjha_Formul.26 Apr 2024

₹

+0.50 (+2.60%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
26-Mar-2024	BC	UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2024 inter alia to consider and approve Ref: Clause 29(1)(a) of SEBI(Listing Ob	29-Mar-2024
18-Jan-2024	BC	UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve Ref : Clause 29(a) of Listing Agreement	29-Jan-2024
23-Oct-2023	BC	UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 ,inter alia, to consider and approve Regu 29(1)(a) of Listing Agreement	09-Nov-2023
06-Oct-2023	BC	Notice of Extra Ordinary General Meeting (EGM) and intmation of Cut of Date BC and e-voting Regulation 42(2) of SEBI(LODR) Regulations 2015 Proceeding of the Extra Ordinary General Meeting of t	06-Nov-2023
06-Oct-2023	BC	Regulation 42(2) of SEBI(LODR) Regulations 2015	31-Oct-2023

No Rights has been declared by Unjha_Formul.

Book Closure

Record Date	Split Date	Purpose
29-Mar-2024	-	UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2024 inter alia to consider and approve Ref: Clause 29(1)(a) of SEBI(Listing Ob
29-Jan-2024	-	UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve Ref : Clause 29(a) of Listing Agreement
09-Nov-2023	-	UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 ,inter alia, to consider and approve Regu 29(1)(a) of Listing Agreement
06-Nov-2023	-	Notice of Extra Ordinary General Meeting (EGM) and intmation of Cut of Date BC and e-voting Regulation 42(2) of SEBI(LODR) Regulations 2015 Proceeding of the Extra Ordinary General Meeting of t
31-Oct-2023	01 Jan'1900	Regulation 42(2) of SEBI(LODR) Regulations 2015

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Unjha Formulations Ltd ₹19.75(+0.50/2.60%)	19.75	+0.50	8.85	52.63	38.73	3.51
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	5.55	4.76	3.76	2.84	3.21	4.62
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	5.55	4.76	3.76	2.84	3.21	4.62
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.01	-0.01	0.01	0.02	0.01
Total Income	5.54	4.77	3.75	2.84	3.23	4.63
Total Expenditure	5.13	4.87	3.55	2.95	3.30	4.05
PBIDT	0.41	-0.10	0.20	-0.11	-0.07	0.58
Interest	0.00	0.02	0.02	0.02	0.02	0.02
PBDT	0.41	-0.12	0.19	-0.13	-0.09	0.56
Depreciation	0.02	0.00	0.00	0.05	0.00	0.01
Tax	0.00	0.00	0.00	0.05	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.39	-0.12	0.18	-0.22	-0.09	0.55
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.39	-0.12	0.18	-0.22	-0.09	0.55

EPS (Unit Curr.)	0.87	-0.26	0.40	-0.50	-0.21	1.23
EPS (Adj) (Unit Curr.)	0.87	-0.26	0.40	-0.50	-0.21	1.23
Calculated EPS (Unit Curr.)	0.87	-0.26	0.40	-0.50	-0.21	1.23
Calculated EPS (Adj) (Unit Curr.)	0.87	-0.26	0.40	-0.50	-0.21	1.23
Calculated EPS (Ann.) (Unit Curr.)	3.47	-1.04	1.62	-2.00	-0.84	4.91
Calculated EPS (Adj) (Ann.) (Unit Curr.)	3.47	-1.04	1.62	-2.00	-0.84	4.91
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	4.48	4.48	4.48	4.48	4.48	4.48
Reserve & Surplus	0.20	0.20	0.20	0.20	0.20	0.20
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	7.39	-2.10	5.32	-3.87	-2.18	12.55
PBDTM(%)	7.39	-2.52	5.05	-4.58	-2.80	12.12
PATM(%)	7.03	-2.52	4.79	-7.75	-2.80	11.90

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.48	4.48	4.48	4.48	4.48	4.48
Reserves Total	-2.03	-2.31	-2.56	-2.67	-2.97	-3.27
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	2.45	2.17	1.92	1.81	1.51	1.21
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	2.45	2.17	1.92	1.81	1.51	1.21
APPLICATION OF FUNDS :
Gross Block	1.10	1.07	1.12	4.16	1.12	4.02
Less : Accumulated Depreciation	0.00	0.00	0.00	3.02	0.00	2.86
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1.10	1.07	1.12	1.14	1.12	1.16
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1.14	1.07	1.15	0.48	0.55	1.02
Sundry Debtors	1.05	0.70	0.98	1.15	1.34	0.78
Cash and Bank	0.01	0.43	0.17	0.94	0.65	0.49
Loans and Advances	0.12	0.19	0.11	0.00	0.00	0.27
Total Current Assets	2.31	2.38	2.40	2.57	2.54	2.56
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.96	1.28	1.61	1.90	2.15	2.75
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.96	1.28	1.61	1.90	2.15	2.75
Net Current Assets	1.36	1.10	0.79	0.67	0.39	-0.19
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	2.46	2.17	1.91	1.81	1.51	0.97
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.43	0.17	0.94	0.65	0.49
Net Cash from Operating Activities	-0.31	0.28	-0.70	0.39	-0.12
Net Cash Used In Investing Activities	-0.10	-0.02	-0.06	-0.10	0.04
Net Cash Used In Financing Activities	0.00	0.00	0.00	0.00	0.23
Net Inc./Dec In Cash And Cash Equivalents	-0.42	0.25	-0.77	0.29	0.16
Cash And Cash Equivalents At End Of The Year	0.01	0.43	0.17	0.94	0.65

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

36.92%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

63.08%

**Promoter pledged shareholding 36.92%

About Unjha Formulations Ltd

Unjha Formulations Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 8.85 crores. It has reported a sales of Rs. 5.55 crores and a net profit of Rs. 0.39 crores for the quarter ended December 2018. The company management includes Jashodaben S Patel, Krutiben M Patel,Hasmukh C Chavda,Jashodaben S Patel,Jitendrakumar Parshottamdas Limbachiya,Jigar Ray,Mustufa Najmuddin,Esham. Patel (Unjha Formulations Ltd) among others.

Chairman

Jashodaben S Patel

Registered office

Khali Char Rasta,State Highway Ta Sidhpur,Patan,Gujarat,384151

FAX :91-2767-282396

Background

Incorporation Year1994

Face Value₹10

Market Lot1

How to buy Unjha Formul. shares on nse?

To buy Unjha Formul. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Unjha Formul. share price today?

The Unjha Formul. shares price on nse is Rs.19.75 today.

What is the market cap of Unjha Formul. shares on BSE ?

The company has a market capitalization of Rs.8.85Cr

What is the PE & PB ratio of Unjha Formul. shares ?

PE is 38.73 and PB is 3.51

What is the 52 Week High and Low of Unjha Formul. shares?

Unjha Formul. stock price high: Rs.24.87 Unjha Formul. stock price low: Rs.10.55